Trials / Completed
CompletedNCT05592444
Strategies to Reduce Contrast Medium in Spectral CT Pulmonary Angiography
Different Strategies to Reduce Contrast Medium in Computed Tomography Pulmonary Angiography Using Spectral Detector CT
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 330 (actual)
- Sponsor
- University Hospital, Akershus · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effect of three different strategies to inject at reduced volume of contrast medium in Computed Tomography Pulmonary Angiography (CTPA). 330 patients referred for CTPA are randomized to receive either a low-concentration, a low-volume or a saline-diluted injection. Effects on the level and homogeneity of contrast enhancement are measured and compared between groups.
Detailed description
Spectral detector CT facilitates large reductions in contrast medium in vascular CT examinations. To our knowledge, no studies have so far compared different strategies to inject this reduced contrast dose. The purpose of this study is to assess the effect of three different strategies to inject at reduced volume of contrast medium in Computed Tomography Pulmonary Angiography (CTPA). 330 patients referred for clinically indicated CTPA are randomized to receive either a low-concentration, a low-volume or a saline-diluted injection. All patients receive the same amount of iodine (140 mg/kg). Effects on the level and homogeneity of contrast enhancement, image noise, contrast-to-noise-ratio and signal-to-noise-ratio are measured in the CT images and the results are compared between groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Low iodine Spectral Detector CT Pulmonary Angiography | Low iodine Spectral Detector CT Pulmonary Angiography |
Timeline
- Start date
- 2020-11-23
- Primary completion
- 2021-10-12
- Completion
- 2021-10-12
- First posted
- 2022-10-24
- Last updated
- 2024-04-16
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT05592444. Inclusion in this directory is not an endorsement.